We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

2 hedge funds and large institutions have $27K invested in Bioverativ Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 449 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 459 → 2 (-457)

100% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 449

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $5.76B → $27K (-$5.76B)

Holders
2
Holders Change
-457
Holders Change %
-99.56%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
449
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACS
Archford Capital Strategies
Illinois
+$2.28K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$585M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$497M
3
Primecap Management
Primecap Management
California
-$411M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$274M
5
State Street
State Street
Massachusetts
-$232M
Name Holding Trade Value Shares
Change 		Change in
Stake
VMPIC
226
Varma Mutual Pension Insurance Co
Finland
– -$539K -10,000 Closed
PPCM
227
Pillar Pacific Capital Management
California
– -$520K -9,647 Closed
AA
228
ALPS Advisors
Colorado
– -$518K -9,614 Closed
CEP
229
Chicago Equity Partners
Illinois
– -$517K -9,590 Closed
M&T Bank
230
M&T Bank
New York
– -$512K -9,501 Closed
DADC
231
D.A. Davidson & Co
Montana
– -$497K -9,210 Closed
ECM
232
ETrade Capital Management
Virginia
– -$494K -9,163 Closed
OAM
233
Oxford Asset Management
United Kingdom
– -$484K -8,975 Closed
LIA
234
LS Investment Advisors
Michigan
– -$481K -8,929 Closed
SCM
235
Shelton Capital Management
Colorado
– -$464K -8,609 Closed
GF
236
Gabelli Funds
New York
– -$458K -8,500 Closed
WIS
237
Wright Investors Service
Connecticut
– -$447K -8,288 Closed
LD
238
Lipe & Dalton
New York
– -$430K -7,968 Closed
SOADOR
239
State of Alaska Department of Revenue
Alaska
– -$428K -7,950 Closed
MCM
240
Mitchell Capital Management
Kansas
– -$428K -7,934 Closed
OAM
241
Oppenheimer Asset Management
New York
– -$453K -7,923 Closed
HighTower Advisors
242
HighTower Advisors
Illinois
– -$430K -7,816 Closed
FCM
243
Flinton Capital Management
Pennsylvania
– -$418K -7,760 Closed
Envestnet Asset Management
244
Envestnet Asset Management
Illinois
– -$415K -7,700 Closed
WAM
245
World Asset Management
Michigan
– -$405K -7,516 Closed
CL
246
CIM LLC
New York
– -$397K -7,360 Closed
US Bancorp
247
US Bancorp
Minnesota
– -$396K -7,348 Closed
RGC
248
Roberts, Glore & Co
Illinois
– -$392K -7,279 Closed
SBH
249
Segall Bryant & Hamill
Illinois
– -$389K -7,207 Closed
SB
250
Suntrust Banks
Georgia
– -$372K -6,881 Closed
8 9
10
11 12

BIVV Hedge Fund Activity: Q1 2018 in Review

2 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2018, worth a combined $27K — down 100% from $5.76B a quarter earlier.

Sellers outnumbered buyers: 449 funds closed out of BIVV and 1 opened new positions — a net loss of 448 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Archford Capital Strategies, opening a new position worth an estimated $2.28K. The largest seller was BlackRock, exiting entirely with an estimated $585M sold.

  • 2 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2018, down from 459 in Q4 2017.
  • Funds reported $27K of Bioverativ Inc. Common Stock stock for Q1 2018, down 100% quarter-over-quarter.
  • 1 fund opened new Bioverativ Inc. Common Stock positions in Q1 2018 and 449 closed out, a net change of -448 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2018 was Archford Capital Strategies, an estimated $2.28K added.
  • The largest Bioverativ Inc. Common Stock seller in Q1 2018 was BlackRock, an estimated $585M sold.

Based on aggregated 13F filings for Q1 2018.